Article and Video CATEGORIES
Here's a video presentation on never-smokers with lung cancer, a population that has been a subject of great interest to me for the past several years. Ten years ago, we really didn't focus on smoking status as a relevant issue and didn't break out never-smokers as a group within our lung cancer trials. Over the last few years, and largely on the basis of differences in outcomes that became more clear with the introduction of the EGFR inhibitors, we're coming to recognize that never-smokers with lung cancer may really represent a distinct disease, with different demographics, pathology subtypes, response to treatments, and overall survival. This video provides a brief overview of the highlights of what we know about never-smokers with lung cancer.
[powerpress]
For those using the audio program, the figures are included below, to follow along. The transcript is also below.
Never-Smokers with Lung Cancer Figures
Never-Smokers with Lung Cancer Transcript
Special thanks to Melissa Zhao for sponsoring this program in loving memory of her husband, Zhuan Mike Chen, for the benefit of never-smokers with lung cancer everywhere.
Please feel free to offer comments and raise questions in our
discussion forums.
Forum Discussions
Hi elysianfields and welcome to Grace. I'm sorry to hear about your father's progression.
Unfortunately, lepto remains a difficult area to treat. Recently FDA approved the combo Lazertinib and Amivantamab...
Hello Janine, thank you for your reply.
Do you happen to know whether it's common practice or if it's worth taking lazertinib without amivantamab? From all the articles I've come across...
Hi elysianfields,
That's not a question we can answer. It depends on the individual's health. I've linked the study comparing intravenous vs. IV infusions of the doublet lazertinib and amivantamab...
Recent Comments
That's…